FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer — NEJM
Original Article FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Thierry Conroy, M.D., Françoise Desseigne, M.D., Marc Ychou, M.D., Ph.D., Olivier Bouché, M.D., Ph.D., Rosine Guimbaud, M.D., Ph.D., Yves Bécouarn, M.D., Antoine Adenis, M ......